NILES, Ill. and BIRMINGHAM, Mich.—M&S Technologies and MacuHealth, LP have entered into a cooperative marketing agreement. The two companies issued a statement saying they will educate and train eyecare professionals on the direct relationship between enriching macular pigment with nutritional supplements and optimizing visual performance.

“As more and more optometric practices move toward the medical model, the combined body of scientific and clinical evidence available through M&S technologies and MacuHealth's unique formulation will help advance the quality of patient care,” the companies said.

Each company brings complimentary capabilities to the partnership. M&S Technologies has developed peer-reviewed testing methods that are calibrated to ANSI and ISO specifications, including a way of measuring contrast sensitivity. MacuHealth has a significant body of peer-reviewed evidence to support the safety and efficacy of its ocular health supplements.

M&S and MacuHealth said they are preparing to launch cooperative programs to help ECPs purchase M&S contrast sensitivity technology or upgrade existing M&S technology in their practices. These programs will combine vision testing with MacuHealth’s supplements.